A Study of Esomeprazole in Children With Autism

    Not Recruiting
  • End date
    Dec 24, 2022
  • participants needed
  • sponsor
    Stanford University
Updated on 5 March 2022
pervasive developmental disorder
developmental disabilities


Autism is a pervasive developmental disorder characterized by core deficits in social behavior and communication and the presence of repetitive/stereotyped behaviors. The objective of the study is to evaluate the efficacy of Esomeprazole as a treatment for social communication deficits in children with Autism Spectrum Disorder (ASD). This prospective 12 week open-label study will invite 25 children with ASD between the ages of 2 and 6 years of age to participate.

Condition Pervasive developmental disorder, Autism, Autism, Autism Spectrum Disorder (ASD), Autism Spectrum Disorder, Autism Spectrum Disorder (ASD), autism spectrum disorders, autistic
Treatment Esomeprazole
Clinical Study IdentifierNCT03866668
SponsorStanford University
Last Modified on5 March 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note